Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies.

PubWeight™: 2.82‹?› | Rank: Top 1%

🔗 View Article (PMC 3664422)

Published in J Neurochem on September 20, 2011

Authors

Daniah Trabzuni1, Mina Ryten, Robert Walker, Colin Smith, Sabaena Imran, Adaikalavan Ramasamy, Michael E Weale, John Hardy

Author Affiliations

1: Reta Lilla Weston Laboratories and Departments of Molecular Neuroscience, UCL Institute of Neurology, London, UK.

Articles citing this

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron (2011) 18.73

Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73

ADCY5 mutations are another cause of benign hereditary chorea. Neurology (2015) 3.04

Mutations in HPCA cause autosomal-recessive primary isolated dystonia. Am J Hum Genet (2015) 2.98

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease. Nature (2013) 2.79

Common genetic variants influence human subcortical brain structures. Nature (2015) 2.40

Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci (2014) 2.23

Mutations in the autoregulatory domain of β-tubulin 4a cause hereditary dystonia. Ann Neurol (2013) 1.90

Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol (2014) 1.88

Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. Am J Hum Genet (2012) 1.78

Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet (2014) 1.71

MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies. Hum Mol Genet (2012) 1.58

Insights from cerebellar transcriptomic analysis into the pathogenesis of ataxia. JAMA Neurol (2014) 1.51

Insights into TREM2 biology by network analysis of human brain gene expression data. Neurobiol Aging (2013) 1.49

PRRT2 Is a Key Component of the Ca(2+)-Dependent Neurotransmitter Release Machinery. Cell Rep (2016) 1.46

Genome-wide association study in essential tremor identifies three new loci. Brain (2016) 1.43

Integration of GWAS SNPs and tissue specific expression profiling reveal discrete eQTLs for human traits in blood and brain. Neurobiol Dis (2012) 1.35

Gene expression changes with age in skin, adipose tissue, blood and brain. Genome Biol (2013) 1.34

Resolving the polymorphism-in-probe problem is critical for correct interpretation of expression QTL studies. Nucleic Acids Res (2013) 1.25

Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation. Br J Cancer (2012) 1.19

Widespread sex differences in gene expression and splicing in the adult human brain. Nat Commun (2013) 1.15

Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. Nat Rev Genet (2015) 1.14

Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease. PLoS One (2014) 1.11

A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry (2015) 1.10

Novel C12orf65 mutations in patients with axonal neuropathy and optic atrophy. J Neurol Neurosurg Psychiatry (2013) 1.06

Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk Loci. Ann Hum Genet (2013) 1.02

Recursive splicing in long vertebrate genes. Nature (2015) 1.01

Alpha-synuclein mRNA expression in oligodendrocytes in MSA. Glia (2014) 0.99

A Bayesian method to incorporate hundreds of functional characteristics with association evidence to improve variant prioritization. PLoS One (2014) 0.99

Truncating and missense mutations in IGHMBP2 cause Charcot-Marie Tooth disease type 2. Am J Hum Genet (2014) 0.98

A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystonia. Am J Hum Genet (2015) 0.93

Mutations in SNX14 cause a distinctive autosomal-recessive cerebellar ataxia and intellectual disability syndrome. Am J Hum Genet (2014) 0.92

Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependence. Transl Psychiatry (2015) 0.90

Genetic comorbidities in Parkinson's disease. Hum Mol Genet (2013) 0.89

Hypermethylation in the ZBTB20 gene is associated with major depressive disorder. Genome Biol (2014) 0.88

Age-associated changes in gene expression in human brain and isolated neurons. Neurobiol Aging (2012) 0.87

De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions. Am J Hum Genet (2016) 0.86

Gene expression in the Parkinson's disease brain. Brain Res Bull (2011) 0.85

Investigating the utility of human embryonic stem cell-derived neurons to model ageing and neurodegenerative disease using whole-genome gene expression and splicing analysis. J Neurochem (2012) 0.83

Genomewide association study in cervical dystonia demonstrates possible association with sodium leak channel. Mov Disord (2013) 0.83

A FreeSurfer view of the cortical transcriptome generated from the Allen Human Brain Atlas. Front Neurosci (2015) 0.82

Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus. PLoS One (2013) 0.82

Genome-wide analyses for personality traits identify six genomic loci and show correlations with psychiatric disorders. Nat Genet (2016) 0.82

The clinical and genetic heterogeneity of paroxysmal dyskinesias. Brain (2015) 0.82

Investigating cell death mechanisms in amyotrophic lateral sclerosis using transcriptomics. Front Cell Neurosci (2013) 0.82

Gene co-expression networks shed light into diseases of brain iron accumulation. Neurobiol Dis (2015) 0.81

GABRA2 Alcohol Dependence Risk Allele is Associated with Reduced Expression of Chromosome 4p12 GABAA Subunit Genes in Human Neural Cultures. Alcohol Clin Exp Res (2015) 0.81

Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme CYP24A1 in multiple sclerosis. Mult Scler Relat Disord (2014) 0.80

Microglia recapitulate a hematopoietic master regulator network in the aging human frontal cortex. Neurobiol Aging (2015) 0.80

Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy. Neurobiol Aging (2014) 0.79

Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers. Acta Neuropathol (2017) 0.79

Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain Aging. Cell Rep (2017) 0.78

A pilot integrative genomics study of GABA and glutamate neurotransmitter systems in suicide, suicidal behavior, and major depressive disorder. Am J Med Genet B Neuropsychiatr Genet (2016) 0.78

A Polymorphic Antioxidant Response Element Links NRF2/sMAF Binding to Enhanced MAPT Expression and Reduced Risk of Parkinsonian Disorders. Cell Rep (2016) 0.78

Frontotemporal dementia: insights into the biological underpinnings of disease through gene co-expression network analysis. Mol Neurodegener (2016) 0.78

Genome-wide association study of positive emotion identifies a genetic variant and a role for microRNAs. Mol Psychiatry (2016) 0.77

Genetic analysis in neurology: the next 10 years. JAMA Neurol (2013) 0.77

Limited predictability of postmortem human brain tissue quality by RNA integrity numbers. J Neurochem (2016) 0.76

Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis. Neurobiol Aging (2016) 0.76

Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging. Acta Neuropathol (2016) 0.76

Allele-Skewed DNA Modification in the Brain: Relevance to a Schizophrenia GWAS. Am J Hum Genet (2016) 0.76

Decreasing the expression of PICALM reduces endocytosis and the activity of β-secretase: implications for Alzheimer's disease. BMC Neurosci (2016) 0.76

Genome-wide association study of neocortical Lewy-related pathology. Ann Clin Transl Neurol (2015) 0.76

An endophenotype approach to the genetics of alcohol dependence: a genome wide association study of fast beta EEG in families of African ancestry. Mol Psychiatry (2017) 0.76

Whole genome sequence association and ancestry-informed polygenic profile of EEG alpha in a Native American population. Am J Med Genet B Neuropsychiatr Genet (2017) 0.75

Molecular mechanisms underlying noncoding risk variations in psychiatric genetic studies. Mol Psychiatry (2017) 0.75

DRD2 co-expression network and a related polygenic index predict imaging, behavioral and clinical phenotypes linked to schizophrenia. Transl Psychiatry (2017) 0.75

Gene-based association study of genes linked to hippocampal sclerosis of aging neuropathology: GRN, TMEM106B, ABCC9, and KCNMB2. Neurobiol Aging (2017) 0.75

Replicated Risk Nicotinic Cholinergic Receptor Genes for Nicotine Dependence. Genes (Basel) (2016) 0.75

Assessment of Three New Loci from Genome-wide Association Study in Essential Tremor in Chinese population. Sci Rep (2017) 0.75

A Genome Wide Association Study of Fast Beta EEG in Families of European Ancestry. Int J Psychophysiol (2016) 0.75

Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson's disease on chromosome 7p15.3. Neurogenetics (2017) 0.75

Articles cited by this

Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19

The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol (2006) 13.13

A survey of genetic human cortical gene expression. Nat Genet (2007) 12.04

Evaluation of DNA microarray results with quantitative gene expression platforms. Nat Biotechnol (2006) 8.87

mRNA stability in mammalian cells. Microbiol Rev (1995) 8.78

Evidence based selection of housekeeping genes. PLoS One (2007) 7.90

Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res (2005) 7.63

The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007. Cell Tissue Bank (2008) 4.13

Validity of nucleic acid purities monitored by 260nm/280nm absorbance ratios. Biotechniques (1995) 3.82

Human postmortem tissue: what quality markers matter? Brain Res (2006) 2.92

Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry (2004) 2.53

The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett (1995) 2.35

Cross-platform comparison of SYBR Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray Quality Control (MAQC) study. BMC Genomics (2008) 1.99

Identification of valid reference genes for the normalization of RT qPCR gene expression data in human brain tissue. BMC Mol Biol (2008) 1.62

Sample matching by inferred agonal stress in gene expression analyses of the brain. BMC Genomics (2007) 1.54

Exon array data analysis using Affymetrix power tools and R statistical software. Brief Bioinform (2011) 1.53

Tissue and organ donation for research in forensic pathology: the MRC Sudden Death Brain and Tissue Bank. J Pathol (2007) 1.51

Postmortem interval effect on RNA and gene expression in human brain tissue. Cell Tissue Bank (2010) 1.46

Quality control for microarray analysis of human brain samples: The impact of postmortem factors, RNA characteristics, and histopathology. J Neurosci Methods (2007) 1.44

Effects of antemortem and postmortem variables on human brain mRNA quality: a BrainNet Europe study. J Neuropathol Exp Neurol (2010) 1.36

Brain pH has a significant impact on human postmortem hippocampal gene expression profiles. Brain Res (2006) 1.31

The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue. J Neural Transm (1985) 1.21

Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples. Br J Cancer (2011) 1.18

TaqMan PCR assay in the control of RNA normalization in human post-mortem brain tissue. Neurochem Int (2006) 1.15

pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium. Neuropathol Appl Neurobiol (2009) 1.13

Selection of optimal reference genes for normalization in quantitative RT-PCR. BMC Bioinformatics (2010) 1.11

Effect of pre- and postmortem variables on specific mRNA levels in human brain. Brain Res Mol Brain Res (1991) 1.07

The postmortem Alzheimer brain is a source of structurally and functionally intact astrocytic messenger RNA. J Neurosci Methods (1988) 1.07

Long-term stability of RNA in post-mortem bovine skeletal muscle, liver and subcutaneous adipose tissues. BMC Mol Biol (2007) 0.99

Assessing RNA quality in postmortem human brain tissue. Exp Mol Pathol (2007) 0.99

RNA integrity in post mortem human variant Creutzfeldt-Jakob disease (vCJD) and control brain tissue. Neuropathol Appl Neurobiol (2011) 0.94

mRNA profiling in forensic genetics I: Possibilities and limitations. Forensic Sci Int (2010) 0.93

The preparation of biologically active messenger RNA from human postmortem brain tissue. J Neurochem (1981) 0.92

Expression profile analysis of neurodegenerative disease: advances in specificity and resolution. Neurochem Res (2004) 0.91

Whole genome expression as a quantitative trait. Biochem Soc Trans (2009) 0.86

Articles by these authors

Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron (2011) 18.73

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet (2011) 13.10

A survey of genetic human cortical gene expression. Nat Genet (2007) 12.04

TREM2 variants in Alzheimer's disease. N Engl J Med (2012) 11.35

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet (2011) 9.10

A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet (2010) 8.48

A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry (2007) 7.23

GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron (2007) 6.88

Parkinson's disease. Lancet (2009) 6.60

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci U S A (2003) 6.46

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18

Toxic proteins in neurodegenerative disease. Science (2002) 5.82

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52

Genome-wide SNP assay reveals structural genomic variation, extended homozygosity and cell-line induced alterations in normal individuals. Hum Mol Genet (2006) 5.50

Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol (2012) 5.18

A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet (2009) 5.01

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov (2010) 4.55

Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol (2013) 4.29

Genome-wide association study identifies five loci associated with lung function. Nat Genet (2009) 4.10

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain (2009) 4.01

Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol (2007) 3.93

Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. Am J Hum Genet (2012) 3.80

Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlanders. Proc Natl Acad Sci U S A (2010) 3.78

Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73

Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. JAMA Neurol (2013) 3.70

Meningiomas. Lancet (2004) 3.69

Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol (2009) 3.62

Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol (2010) 3.61

Evolutionary toggling of the MAPT 17q21.31 inversion region. Nat Genet (2008) 3.42

Orphan CpG islands identify numerous conserved promoters in the mammalian genome. PLoS Genet (2010) 3.38

Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med (2003) 3.37

Genetic control of human brain transcript expression in Alzheimer disease. Am J Hum Genet (2009) 3.35

Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet (2010) 3.34

Research ethics in victimization studies: widening the lens. Violence Against Women (2011) 3.30

Chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiol Aging (2011) 3.27

Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus. Nat Commun (2011) 3.23

CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum Mol Genet (2004) 3.12

Long-range LD can confound genome scans in admixed populations. Am J Hum Genet (2008) 3.06

Identification of IL6R and chromosome 11q13.5 as risk loci for asthma. Lancet (2011) 3.03

Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet (2011) 3.03

DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. Lancet Neurol (2008) 3.03

Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci U S A (2005) 3.02

Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet (2011) 2.97

Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease. Neurobiol Aging (2003) 2.96

Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study. Lancet Neurol (2007) 2.88

Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Genome Biol (2004) 2.77

Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron (2002) 2.65

Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain (2012) 2.65

Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J (2003) 2.64

Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol (2009) 2.60

Repeat expansion in C9ORF72 in Alzheimer's disease. N Engl J Med (2012) 2.58

Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One (2010) 2.57

Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet (2010) 2.51

Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Ann Neurol (2010) 2.48

ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. Mov Disord (2010) 2.47

The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis (2006) 2.42

β-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation. Brain (2013) 2.40

The T allele of a single-nucleotide polymorphism 13.9 kb upstream of the lactase gene (LCT) (C-13.9kbT) does not predict or cause the lactase-persistence phenotype in Africans. Am J Hum Genet (2004) 2.39

Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet (2011) 2.35

A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol (2013) 2.32

Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight. Nat Genet (2010) 2.30

Antiamyloid therapy for Alzheimer's disease--are we on the right road? N Engl J Med (2014) 2.29

Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain (2012) 2.28

Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation. Ann Neurol (2003) 2.23

Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Ann Neurol (2012) 2.20

The gonadotrophins response to GnRH test is not a predictor of neurological lesion in girls with central precocious puberty. J Pediatr Endocrinol Metab (2005) 2.17

Genome-wide association study of major recurrent depression in the U.K. population. Am J Psychiatry (2010) 2.17

Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain (2011) 2.13

Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans. PLoS Genet (2007) 2.09

Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am J Hum Genet (2013) 2.09

Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08

A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. Am J Hum Genet (2005) 2.04

Identical twins with Leucine rich repeat kinase type 2 mutations discordant for Parkinson's disease. Mov Disord (2012) 2.02

Cattle domestication in the Near East was followed by hybridization with aurochs bulls in Europe. Proc Biol Sci (2005) 2.01

The neuropathology and neurobiology of traumatic brain injury. Neuron (2012) 1.99

Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci (2005) 1.99

The Ischemic Stroke Genetics Study (ISGS) Protocol. BMC Neurol (2003) 1.98

Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A. Brain (2013) 1.95

Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc Natl Acad Sci U S A (2004) 1.95

A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. Hum Mol Genet (2009) 1.93

Mutations in the autoregulatory domain of β-tubulin 4a cause hereditary dystonia. Ann Neurol (2013) 1.90

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90